UnitedHealth Group Incorporated stock is oversold, trading at 12x 2026 profits with a 3.3% dividend yield. Click for more on ...

Steve Weiss, Founder and Managing Partner of Short Hills Capital Partners joins CNBC’s “Halftime Report” to detail his latest ...

Parnassus Investments, an investment management firm that focuses on owning a concentrated portfolio of U.S. large cap stocks ...

Staffing shortages, rising prescription drug use, and costly new therapies have driven inflation in the medical sector.

"While the $16 EPS floor was lower than expected, it does give investors/analysts a base to model off of, and potentially ...

Returning CEO Stephen Hemsley is lowering expectations, but perhaps not enough.

UnitedHealth Group faces deteriorating margins and earnings, with bearish trends persisting after FY25 Q2 results. Click for ...

UnitedHealth delivered disappointing second-quarter earnings and went conservative with its 2025 forecast as soaring medical ...

The conglomerate was viewed as one of the most successful companies in America, but patients are enraged and investors have ...

UnitedHealth missed Wall Street’s second-quarter earnings expectations and offered a new and conservative take on the rest of ...

UnitedHealth's newly returned CEO, Stephen Hemsley, will likely face investor scrutiny over the largest U.S. health insurance ...